VITAFOXO logo

VITAFOXO
VitaFOXO

0
Mkt Cap
$0.00
24H Volume
$691.61
FDV
$158,659.00
Circ Supply
0.00
Total Supply
10M
VITAFOXO Fundamentals
Max Supply
10M
7D High
$0.033
7D Low
$0.0153
24H High
$0.0159
24H Low
$0.0153
All-Time High
$0.0606
All-Time Low
$0.0146
VITAFOXO Prices
VITAFOXO / USD
$0.0159
VITAFOXO / EUR
€0.0136
VITAFOXO / GBP
£0.0118
VITAFOXO / CAD
CA$0.0218
VITAFOXO / AUD
A$0.0222
VITAFOXO / INR
₹1.53
VITAFOXO / NGN
NGN 21.77
VITAFOXO / NZD
NZ$0.027
VITAFOXO / PHP
₱0.9746
VITAFOXO / SGD
SGD 0.0203
VITAFOXO / ZAR
ZAR 0.2612
Loading...
Loading...

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available
News
all
press releases
No VITAFOXO.X news at the moment.
<
...
1
>

Sentiment

Indicates whether most users posting on a symbol’s stream over the last 24 hours are bearish or bullish.
0
25
50
75
100
Extremely
Bearish
Neutral
Bullish
Extremely
Bearish
Bullish
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Message Volume

Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Participation Ratio

Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

AboutThis project will design a new RNA therapeutic that nudges the longevity-linked FOXO3 gene into its health-promoting form to halt the tissue breakdown behind degenerative disc disease—opening a precise, scalable route to drugs that extend healthspan. Dr. Lorna Harries’ lab has identified an innovative way to modulate FOXO3, a well known and yet undrugged longevity target, and propose leveraging it to address chronic lower back pain stemming from degenerative disc disease. They plan to make short, lab-made modified RNA molecules (antisense oligonucleotides) that selectively switch FOXO3’s “good” message on, first in human cells and mini-disc models. Success would yield 1) a lead drug candidate, 2) proof it can restore disc health, and 3) the data needed for patenting and further development. The same molecules could later be adapted to treat many other age-related conditions, helping people stay healthy for longer.
Details
Categories
Base EcosystemDecentralized Science (DeSci)
Date
Market Cap
Volume
Close
May 20, 2026
$0.00
$691.61
---
May 20, 2026
$0.00
$754.22
---
May 19, 2026
$0.00
$1,302.46
$0.016
May 18, 2026
$0.00
$560.67
$0.0156
May 17, 2026
$0.00
$276.05
$0.0159
May 16, 2026
$0.00
$1,268.03
$0.0161
May 15, 2026
$0.00
$529.60
$0.0167
May 14, 2026
$0.00
$484.52
$0.0167
May 13, 2026
$0.00
$169.21
$0.0166
May 12, 2026
$0.00
$1,366.33
$0.0169

Poll

When it comes to gaining exposure to crypto, which vehicle do you prefer? *Powered by CoinShares
Direct exposure through a crypto exchange
Crypto ETFs
Indirect exposure through crypto-related stocks
Other (Comment)

Latest VITAFOXO News

Top Discussions

Advertisement|Remove ads.